NO20052343L - Doseringsform av natrium ibuprofen - Google Patents
Doseringsform av natrium ibuprofenInfo
- Publication number
- NO20052343L NO20052343L NO20052343A NO20052343A NO20052343L NO 20052343 L NO20052343 L NO 20052343L NO 20052343 A NO20052343 A NO 20052343A NO 20052343 A NO20052343 A NO 20052343A NO 20052343 L NO20052343 L NO 20052343L
- Authority
- NO
- Norway
- Prior art keywords
- sodium ibuprofen
- tablet core
- weight
- water content
- dosage form
- Prior art date
Links
- PTTPUWGBPLLBKW-UHFFFAOYSA-M sodium;2-[4-(2-methylpropyl)phenyl]propanoate Chemical compound [Na+].CC(C)CC1=CC=C(C(C)C([O-])=O)C=C1 PTTPUWGBPLLBKW-UHFFFAOYSA-M 0.000 title abstract 4
- 239000002552 dosage form Substances 0.000 title 1
- 239000003826 tablet Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000007938 effervescent tablet Substances 0.000 abstract 1
- 239000007888 film coating Substances 0.000 abstract 1
- 238000009501 film coating Methods 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 238000009495 sugar coating Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En ikke-brusende tablett av ibuprofen, omfattende en tablettkjerne og, hvis ønskelig, et sukker- eller filmbelegg, hvor tablettkjernen basert på vekten av tablettkjernen, består av 50 til 100 vekt% natriumibuprofenhydrat og 50 til 0 vekt% hjelpematerialkomponent og inneholder intet smøremiddel og ingen disintegrant, og hvor natriumibuprofenhydratet har et vanninnhold på 8 til 16 vekt%, fortrinnsvis 11 - 16 vekt%, har en tilstrekkelig hardhet, er sammenligningsmessig liten og fører til en spesielt hurtig økning i blodnivåer og derved til en akselerert start av analgesisk effekt. I motsetning til den nåværende doktrinen er natriumibuprofenhydrat som har et passende vanninnhold tilstrekkelig sammenpressbar.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01703/02A CH693586A8 (de) | 2002-10-14 | 2002-10-14 | Darreichungsform von Ibuprofen-Natrium. |
PCT/CH2003/000662 WO2004035024A1 (en) | 2002-10-14 | 2003-10-09 | Dosage form of sodium ibuprofen |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20052343L true NO20052343L (no) | 2005-06-02 |
Family
ID=28796671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052343A NO20052343L (no) | 2002-10-14 | 2005-05-12 | Doseringsform av natrium ibuprofen |
Country Status (32)
Country | Link |
---|---|
US (1) | US20040102522A1 (no) |
EP (1) | EP1410793B1 (no) |
JP (1) | JP4608316B2 (no) |
KR (1) | KR101046894B1 (no) |
CN (1) | CN100592909C (no) |
AR (1) | AR041428A1 (no) |
AT (1) | ATE309789T1 (no) |
AU (1) | AU2003266094B2 (no) |
BR (1) | BRPI0315248B1 (no) |
CA (1) | CA2500987A1 (no) |
CH (1) | CH693586A8 (no) |
CO (1) | CO5700709A2 (no) |
DE (1) | DE50301661D1 (no) |
DK (1) | DK1410793T3 (no) |
EA (1) | EA007914B1 (no) |
EC (1) | ECSP055793A (no) |
ES (1) | ES2249702T3 (no) |
HR (1) | HRP20050429A2 (no) |
IL (1) | IL167357A (no) |
MA (1) | MA27490A1 (no) |
MX (1) | MXPA05003592A (no) |
MY (1) | MY132858A (no) |
NO (1) | NO20052343L (no) |
NZ (1) | NZ539405A (no) |
PA (1) | PA8586101A1 (no) |
PE (1) | PE20040417A1 (no) |
PL (1) | PL376177A1 (no) |
SI (1) | SI1410793T1 (no) |
TW (1) | TWI262800B (no) |
UA (1) | UA86751C2 (no) |
WO (1) | WO2004035024A1 (no) |
ZA (1) | ZA200502925B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3920358A1 (de) * | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
US6705028B2 (en) * | 2001-09-12 | 2004-03-16 | Honda Giken Kogyo Kabushiki Kaisha | Self-propelled snowplow vehicle |
US20050176809A1 (en) * | 2004-02-05 | 2005-08-11 | Rodlen Laboratories, Inc. | Method and compositions for treatment of painful disorders |
WO2006016125A1 (en) * | 2004-08-12 | 2006-02-16 | Reckitt Benckiser Healthcare (Uk) Limited | Granules comprising a nsaid and a sugar alcohol made by melt extrusion |
US20070077297A1 (en) * | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
WO2006093353A1 (ja) | 2005-03-03 | 2006-09-08 | Takeda Pharmaceutical Company Limited | 放出制御組成物 |
US9205054B2 (en) | 2005-03-22 | 2015-12-08 | Losan Pharma Gmbh | Solubilized ibuprofen |
EP1800667A1 (en) | 2005-12-23 | 2007-06-27 | Losan Pharma GmbH | Rapidly solubilizing ibuprofen granulate |
DE102006029233A1 (de) * | 2006-06-26 | 2007-12-27 | Liedtke, Rainer K., Dr. | Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika |
CL2007002425A1 (es) * | 2006-08-22 | 2008-06-27 | Albermarle Corp | Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica. |
FI20080348A0 (fi) * | 2008-02-15 | 2008-05-09 | Atacama Labs Oy | Uudenlainen farmaseuttinen formulaatio |
US7749537B2 (en) * | 2006-12-04 | 2010-07-06 | Scolr Pharma, Inc. | Method of forming a tablet |
WO2010011522A1 (en) * | 2008-07-21 | 2010-01-28 | Albemarle Corporation | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
US9629809B2 (en) | 2008-07-21 | 2017-04-25 | Si Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
US20110144207A1 (en) * | 2008-08-14 | 2011-06-16 | Shasun Chemicals And Drugs Limited | Aryl alkyl carboxylic acid salts, process for preparation and dosage forms |
UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
AU2015264861C1 (en) * | 2009-06-22 | 2017-11-16 | Pf Consumer Healthcare 1 Llc | Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen |
AU2014200704C1 (en) * | 2009-06-22 | 2018-12-06 | Pf Consumer Healthcare 1 Llc | Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen |
JP2012530781A (ja) * | 2009-06-22 | 2012-12-06 | ワイス・エルエルシー | イブプロフェンナトリウムタブレット、およびイブプロフェンナトリウムを含有する医薬組成物の製造方法 |
FR2997856B1 (fr) * | 2012-11-14 | 2015-04-24 | Pf Medicament | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate |
EP2965746B1 (en) | 2014-07-10 | 2019-03-13 | Santa Farma Ilaç Sanayi A.S. | An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate |
US20180078516A1 (en) * | 2016-09-19 | 2018-03-22 | Innovazone Labs LLC | Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration |
CN113893227B (zh) * | 2021-11-18 | 2023-04-14 | 山东则正医药技术有限公司 | 布洛芬片的制备原料、制备方法和布洛芬片 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5104648A (en) * | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
GB8920693D0 (en) * | 1989-09-13 | 1989-10-25 | Nicholas Kiwi Pty Ltd | Non-effervescent ibuprofen compositions |
CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
GB9224021D0 (en) * | 1992-11-16 | 1993-01-06 | Boots Co Plc | Effervescent compositions |
US6083430A (en) * | 1994-10-28 | 2000-07-04 | Fuisz Technologies Ltd. | Method of preparing a dosage unit by direct tableting and product therefrom |
GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
IT1301966B1 (it) * | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
-
2002
- 2002-10-14 CH CH01703/02A patent/CH693586A8/de not_active IP Right Cessation
-
2003
- 2003-04-03 SI SI200330125T patent/SI1410793T1/sl unknown
- 2003-04-03 DK DK03405225T patent/DK1410793T3/da active
- 2003-04-03 EP EP03405225A patent/EP1410793B1/de not_active Expired - Lifetime
- 2003-04-03 AT AT03405225T patent/ATE309789T1/de not_active IP Right Cessation
- 2003-04-03 DE DE50301661T patent/DE50301661D1/de not_active Expired - Fee Related
- 2003-04-03 ES ES03405225T patent/ES2249702T3/es not_active Expired - Lifetime
- 2003-09-10 UA UAA200504484A patent/UA86751C2/ru unknown
- 2003-09-22 TW TW092126096A patent/TWI262800B/zh active
- 2003-09-29 AR ARP030103544A patent/AR041428A1/es unknown
- 2003-09-30 MY MYPI20033728A patent/MY132858A/en unknown
- 2003-10-09 KR KR1020057006414A patent/KR101046894B1/ko active IP Right Grant
- 2003-10-09 CN CN200380101345A patent/CN100592909C/zh not_active Expired - Fee Related
- 2003-10-09 EA EA200500649A patent/EA007914B1/ru not_active IP Right Cessation
- 2003-10-09 CA CA002500987A patent/CA2500987A1/en not_active Abandoned
- 2003-10-09 BR BRPI0315248A patent/BRPI0315248B1/pt not_active IP Right Cessation
- 2003-10-09 AU AU2003266094A patent/AU2003266094B2/en not_active Expired - Fee Related
- 2003-10-09 MX MXPA05003592A patent/MXPA05003592A/es active IP Right Grant
- 2003-10-09 JP JP2004543886A patent/JP4608316B2/ja not_active Expired - Fee Related
- 2003-10-09 NZ NZ539405A patent/NZ539405A/en unknown
- 2003-10-09 PL PL03376177A patent/PL376177A1/xx not_active Application Discontinuation
- 2003-10-09 WO PCT/CH2003/000662 patent/WO2004035024A1/en active Application Filing
- 2003-10-10 PE PE2003001033A patent/PE20040417A1/es not_active Application Discontinuation
- 2003-10-13 PA PA20038586101A patent/PA8586101A1/es unknown
- 2003-10-14 US US10/683,283 patent/US20040102522A1/en not_active Abandoned
-
2005
- 2005-03-09 IL IL167357A patent/IL167357A/en not_active IP Right Cessation
- 2005-04-11 ZA ZA200502925A patent/ZA200502925B/en unknown
- 2005-05-09 MA MA28268A patent/MA27490A1/fr unknown
- 2005-05-10 CO CO05044513A patent/CO5700709A2/es not_active Application Discontinuation
- 2005-05-12 NO NO20052343A patent/NO20052343L/no not_active Application Discontinuation
- 2005-05-13 EC EC2005005793A patent/ECSP055793A/es unknown
- 2005-05-13 HR HR20050429A patent/HRP20050429A2/xx not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052343L (no) | Doseringsform av natrium ibuprofen | |
IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
MXPA04005790A (es) | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. | |
WO2004017920A3 (en) | Novel biphenyl and biphenyl-like cannabinoids | |
WO2005039485A3 (en) | Gsk-3 inhibitors and uses thereof | |
DE602006008985D1 (de) | Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund | |
BRPI0519016A2 (pt) | agente preventivo ou terapÊutico para distérbios do sono, uso de uma droga, e, mÉtodo para prevenÇço e/ou tratamento de distérbios do sono | |
BRPI0414305A (pt) | sistema de liberação de drogas por via oral | |
FI20000635A0 (fi) | COMT-inhibiittoreiden käyttö analgeettina | |
AR073133A1 (es) | Agente para el tratamiento de enfermedades pulmonares | |
BR0011174A (pt) | Composições, compostos, compostos isolados e métodos para controlar pestes | |
SG147425A1 (en) | Use of a crosslinked or inhibited starch product | |
BR0314804A (pt) | Forma de dosagem de liberação modificada | |
PT1047413E (pt) | Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a | |
DK1651194T3 (da) | Stabile farmaceutiske sammensætninger med kontrolleret frigivelse, hvilke indeholder fenofibrat og pravastatin | |
DK1401279T3 (da) | Acaricidpulver | |
BRPI0417230A (pt) | bactéria produtora da l-treonina pertencente ao gênero escherichia, e, método para produzir l-treonina | |
BRPI0513862A (pt) | métodos de tratar condições oftálmicas | |
AU2003246728A1 (en) | Calcium lactate and whey permeate for lowering the triglyceride level | |
BR0011742A (pt) | Proteção bacteriana | |
DK1414496T3 (da) | Farmaceutisk sammensætning indeholdende en kombination af PPAR-alpha, pravastatin og mindst en polyglycoliseret glycerid | |
TH85777B (th) | รูปแบบยาของโซเดียมไอบูโพรเฟน | |
WO2021034616A8 (en) | Methods of treating a subject with a cdc42-specific inhibitor | |
TH85777A (th) | รูปแบบยาของโซเดียมไอบูโพรเฟน | |
UA73024C2 (en) | 10 % solution of calcium gluconate for injections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |